IP Library Granted Patent US 9,532,997
Granted Patent B2
US 9,532,997 · App. 14/390,731 · Granted Jan 3, 2017

Compositions and methods for promoting intestinal stem cell function

Inventors: Pekka Katajisto (Cambridge, MA); Michael Pacold (Boston, MA); David M. Sabatini (Cambridge, MA); Omer Yilmaz (Ann Arbor, MI)
Assignee: Whitehead Institute for Biomedical Research
A61K31/675A61K31/436A61K31/7076A61K31/7088A61K31/713A61K38/46A61K45/06C12Y301/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,532,997
App. No.
14/390,731
Granted
Jan 3, 2017
Kind
B2
Abstract

Disclosed herein are novel methods and compositions useful for promoting intestinal stem cell function. The methods and compositions are particularly useful for stimulating the proliferation of and/or self-renewal of intestinal stem cells, as well as for minimizing, preventing, or ameliorating cellular damage resulting from incidental or accidental exposure to radiation (e.g., cancer radiation therapy).

Claims (7)

1. A method of stimulating the proliferation and/or self-renewal of one or more intestinal stem cells in mammalian intestinal tissue comprising contacting a population of Paneth cells or Paneth-like cells in the mammalian intestinal tissue with an effective amount of a calorie restriction mimetic, wherein the calorie restriction mimetic comprises an agent that increases the level and/or activity of bone stromal antigen 1 (Bst-1) or a product of Bst-1.

2. A method according to claim 1 wherein the agent stimulates intracellular release of Ca 2+ .

3. A method according to claim 1 wherein the agent induces the ryanodine receptor to release Ca 2+ into the cytosol.

4. A method according to claim 1 wherein the product of Bst-1 comprises cyclic ADP ribose.

5. A method according to claim 1 wherein the calorie restriction mimetic comprises cADPR.

6. A method according to claim 1 , wherein the contacting occurs in vitro.

7. A method according to claim 1 , wherein the contacting occurs in vivo.

Continuity (2)
Provisional Application 61619864 · Apr 3, 2012
Related Publication 20150258124A1 · Sep 17, 2015